Evidence map›Paper›PMID 22095977›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2012

G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors.

Jiao-Hui Wu, Lisheng Zhang, Alexander C Fanaroff, Xinjiang Cai, Krishn C Sharma, Leigh Brian, Sabrina T Exum, Sudha K Shenoy, Karsten Peppel, Neil J Freedman

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets.Research and practice in thrombosis and haemostasis · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. The GRKs Reactome: Role in Cell Biology and Pathology.International journal of molecular sciences · 2021
    Review
  8. Targeting GRK5 for Treating Chronic Degenerative Diseases.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Proinflammatory Cytokines Mediate GPCR Dysfunction.Journal of cardiovascular pharmacology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jiao-Hui WuBox 3187, Duke University Medical Center, Durham, NC 27710, USA.
Lisheng Zhang
Alexander C Fanaroff
Xinjiang Cai
Krishn C Sharma
Leigh Brian
Sabrina T Exum
Sudha K Shenoy
Karsten Peppel
Neil J Freedman
Norwegian Womens Public Health Association · NO

Funding

E3 Ligases and Deubiquitinases in GPCR Down RegulationR01HL080525 · NHLBI · DUKE UNIVERSITY · PI SHENOY, SUDHA K · 2005 to 2014
$3.3M
Desensitization of Vascular Receptor Tyrosine KinasesR01HL077185 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 2005 to 2009
$1.9M
Inflammation in Vein Graft Disease: A Genetic ApproachR01HL072842 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI PEPPEL, KARSTEN · 2004 to 2007
$1.5M
Mechanisms of Arterial Wall-Mediated AtherogenesisR01HL073005 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 2005 to 2008
$1.5M
NHLBI NIH HHS HL072842NHLBI NIH HHS HL73005NHLBI NIH HHS HL77185NHLBI NIH HHS HL80525NHLBI NIH HHS R01 HL072842NHLBI NIH HHS R01 HL073005NHLBI NIH HHS R01 HL077185NHLBI NIH HHS R01 HL080525
6 · The paper itself

Abstract

objectiveG protein-coupled receptor kinase-5 (GRK5) is a widely expressed Ser/Thr kinase that regulates several atherogenic receptors and may activate or inhibit nuclear factor-κB (NF-κB). This study sought to determine whether and by what mechanisms GRK5 affects atherosclerosis. METHODS AND

resultsGrk5(-/-)/Apoe(-/-) mice developed 50% greater aortic atherosclerosis than Apoe(-/-) mice and demonstrated greater proliferation of macrophages and smooth muscle cells (SMCs) in atherosclerotic lesions. In Apoe(-/-) mice, carotid interposition grafts from Grk5(-/-) mice demonstrated greater upregulation of cell adhesion molecules than grafts from wild-type mice and, subsequently, more atherosclerosis. By comparing Grk5(-/-) with wild-type cells, we found that GRK5 desensitized 2 key atherogenic receptor tyrosine kinases: the platelet-derived growth factor receptor-β in SMCs, by augmenting ubiquitination/degradation; and the colony-stimulating factor-1 receptor (CSF-1R) in macrophages, by reducing CSF-1-induced tyrosyl phosphorylation. GRK5 activity in monocytes also reduced migration promoted by the 7-transmembrane receptor for monocyte chemoattractant protein-1 CC chemokine receptor-2. Whereas GRK5 diminished NF-κB-dependent gene expression in SMCs and endothelial cells, it had no effect on NF-κB activity in macrophages.

conclusionsGRK5 attenuates atherosclerosis through multiple cell type-specific mechanisms, including reduction of SMC and endothelial cell NF-κB activity and desensitization of receptor-specific signaling through the monocyte CC chemokine receptor-2, macrophage CSF-1R, and the SMC platelet-derived growth factor receptor-β.

Indexed as

AnimalsApolipoproteins EAtherosclerosisCell MovementCell ProliferationCells, CulturedDisease Models, AnimalEndothelium, VascularG-Protein-Coupled Receptor Kinase 5MaleMiceMice, Inbred C57BLMice, KnockoutMuscle, Smooth, VascularNF-kappa BReceptor, Macrophage Colony-Stimulating FactorApolipoproteins EG-Protein-Coupled Receptor Kinase 5Grk5 protein, mouseNF-kappa BReceptor, Macrophage Colony-Stimulating FactorReceptor, Platelet-Derived Growth Factor betaReceptors, CCR2Receptors, Tumor Necrosis Factor, Type ITlr4 protein, mouseTnfrsf1a protein, mouseToll-Like Receptor 4

Identifiers

PMID22095977
PMCPMC3321515
OpenAlexW2160046990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.